Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism TNNI3K inhibitors(TNNI3 interacting kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC19H23N5O4S |
InChIKeyYUSROMRPOFFTMX-UHFFFAOYSA-N |
CAS Registry1301761-96-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | US | - |